Molecular Diagnosis and Treatment of Hematological Malignancies
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Oncology".
Deadline for manuscript submissions: closed (30 April 2025) | Viewed by 322
Special Issue Editor
Special Issue Information
Dear Colleagues,
If you are working in molecular hematology or treating patients with hematological malignancies, then we invite you to submit your work to our Special Issue, “Molecular Diagnosis and Treatment of Hematological Malignancies”.
Common hematologic malignancies include leukemia, multiple myeloma, and malignant lymphoma. With the development of new technologies, molecular testing is increasingly being used in the field of hematological malignancies. Accurate diagnosis is very important in the treatment of these diseases. This Special Issue will focus on recent advances in the understanding, diagnosis, and treatment of hematological malignancies at the molecular level. Our aim is to highlight new research data and recent developments in hematological oncology using molecular techniques; their use in diagnosis, risk stratification, prognosis; and the innovative therapeutic approaches that have emerged in recent years.
This Special Issue will feature articles from leading scientists and clinicians, aiming to provide a comprehensive picture of the current challenges and opportunities in this field, enhancing knowledge and improving clinical practice.
This Special Issue is open for submissions.
Dr. Panagiotis Zikos
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- hematological malignancies
- leukemia
- multiple myeloma
- lymphoma
- molecular testing
- precision treatment
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
